Safety of Adalimumab in patients with Crohn's Disease: Analysis of global clinical trials

被引：0

作者：

Colombel, J. ^{[1
]}

Pannaccione, R. ^{[2
]}

Sandbom, W. ^{[3
]}

Rutgeerts, P. ^{[4
]}

Hanauer, S. ^{[5
]}

Reinisch, W. ^{[6
]}

Pollack, P. ^{[7
]}

Kent, J. ^{[8
]}

Cardoso, A. ^{[8
]}

Lau, W. ^{[7
]}

机构：

[1] Ctr Hosp Univ Lille, Hop Claude Huriez, Lille, France

[2] Univ Calgary, Dept Med, Calgary, AB, Canada

[3] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA

[4] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

[5] Univ Chicago, Chicago, IL 60637 USA

[6] Med Univ Vienna, Vienna, Austria

[7] Abbott Labs, Parsippany, NJ USA

[8] Abbott Labs, Abbott Pk, IL 60064 USA

来源：

INFLAMMATORY BOWEL DISEASES | 2008年 / 14卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S25 / S25

页数：1

共 50 条

[31] Clinical Experience With Adalimumab in a Multicenter Swiss Cohort of Patients With Crohn's Disease
Stelle, Marc
Nichita, Cristina
Vavricka, Stephane
Rogler, Gerhard
de Saussure, Philippe
Straumann, Alex
Michetti, Pierre
SWISS MEDICAL WEEKLY, 2009, 139 (35-36) : 12S - 12S
[32] Clinical Experience with Adalimumab in a Multicenter Swiss Cohort of Patients with Crohn's Disease
Nichita, Cristina
Stelle, Marc
Vavricka, Stephan
Ali, Abdou El-Wafa
Ballabeni, Pierluigi
de Saussure, Philippe
Straumann, Alex
Rogler, Gerhard
Michetti, Pierre
DIGESTION, 2010, 81 (02) : 78 - 85
[33] Adalimumab for the induction and maintenance of clinical remission in Japanese patients with Crohn's disease
Watanabe, Mamoru
Hibi, Toshifumi
Lomax, Kathleen G.
Paulson, Susan K.
Chao, Jingdong
Alam, M. Shamsul
Camez, Anne
JOURNAL OF CROHNS & COLITIS, 2012, 6 (02): : 160 - 173
[34] Clinical Experience with Adalimumab in a Multicenter Swiss Cohort of Patients with Crohn's Disease
Nichita, Cristina
Stelle, Marc
Vavricka, Stephan R.
El-Wafa, Ali Abdou
De Saussure, Philippe
Straumann, Alex
Rogler, Gerhard
Michetti, Pierre F.
GASTROENTEROLOGY, 2009, 136 (05) : A681 - A681
[35] Efficacy and safety of adalimumab in the treatment of Crohn's disease in children
Manuel Navas-Lopez, Victor
Blasco-Alonso, Javier
Giron-Fernandez-Crehuet, Francisco
Juliana Serrano-Nieto, Maria
Sierra-Salinas, Carlos
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2013, 105 (10) : 579 - 584
[36] Adalimumab safety in patients with Crohn's Disease and previous exposure to infliximab: CHOICE trial
Lichuger, Simon
Binion, David G.
Wolf, David C.
Present, Daniel H.
Lomax, Kathleen G.
Kent, Jeffrey D.
Cardoso, Alexandra T.
Lau, Winnie
GASTROENTEROLOGY, 2008, 134 (04) : A489 - A489
[37] Long-term efficacy and safety of adalimumab in paediatric patients with Crohn's disease
Faubion, W. A.
Dubinsky, M.
Ruemmele, F. M.
Escher, J.
Rosh, J.
Hyams, J. S.
Eichner, S.
Li, Y.
Reilly, N.
Robinson, A. M.
Lazar, A.
JOURNAL OF CROHNS & COLITIS, 2016, 10 : S392 - S393
[38] Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease
Faubion, William A.
Dubinsky, Marla
Ruemmele, Frank M.
Escher, Johanna
Rosh, Joel
Hyams, Jeffrey S.
Eichner, Samantha
Li, Yao
Reilly, Nattanan
Thakkar, Roopal B.
Robinson, Anne M.
Lazar, Andreas
INFLAMMATORY BOWEL DISEASES, 2017, 23 (03) : 453 - 460
[39] Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn's Disease
Ogata, Haruhiko
Watanabe, Mamoru
Matsui, Toshiyuki
Hase, Hidenori
Okayasu, Motohiro
Tsuchiya, Tsuyoshi
Shinmura, Yasuhiko
Hibi, Toshifumi
JOURNAL OF CROHNS & COLITIS, 2016, 10 (09): : 1033 - 1041
[40] Long-Term Efficacy and Safety of Adalimumab in Paediatric Patients With Crohn's Disease
Faubion, William
Dubinsky, Marla
Ruemmele, Frank
Escher, Johanna
Rosh, Joel R.
Hyams, Jeffrey S.
Eichner, Samantha
Li, Yao
Reilly, Nattanan
Robinson, Anne M.
Lazar, Andreas
GASTROENTEROLOGY, 2016, 150 (04) : S775 - S775

← 1 2 3 4 5 →